For cancer patients who have responded poorly to standard treatment or have a high risk of relapse, it’s challenging to envision a good prognosis, but those who are candidates for precision medicine may have reason to feel optimistic.

from Forbes – Tech http://ift.tt/2cExtyk
via IFTTT